Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference

Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry.

Luminex Corporation to Participate at the 2021 Barclays Global Healthcare Conference

Mar 09, 2021 11:35 AM EST

AUSTIN, Texas, March 9, 2021 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, Chairman, CEO & President, and Harriss Currie, Senior Vice President and CFO, plan to participate at the 2021 Barclays Global Healthcare Conference on March 10, 2021 at 8:35 a.m. Eastern Time. A live webcast of the Luminex presentation may be accessed at the company’s website at http://www.luminexcorp.com. The presentation will be archived for six months on the website using the ‘replay’ link.

About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at luminexcorp.com.

Investor Relations Contact:
Harriss Currie
Sr. Vice President and Chief Financial Officer
[email protected]
512-219-8020

Media Contact:
Michele Parisi
Bioscribe
[email protected]
925-864-5028

Luminex logo. (PRNewsFoto/Luminex Corporation)

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-to-participate-at-the-2021-barclays-global-healthcare-conference-301243639.html

SOURCE Luminex Corporation

https://investor.luminexcorp.com/news-releases/news-release-details/luminex-corporation-participate-2021-barclays-global-healthcare